Business
AmeriCann Partners with C3RN to Conduct Scientific Cannabis Research in Massachusetts
AmeriCann Partners with C3RN to Conduct Scientific Cannabis Research in Massachusetts.
About this update from Americann Inc.
[{"type":"text","content":" Research to Commence Immediately with Highly Regarded Team of PhDs, Scientists and ProfessionalsDENVER, CO / ACCESSWIRE / June 20, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an Agricultural-Technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse cannabis cultivation and processing properties, announced today that it is formally partnering with Cannabis Community Care and Research Network (C3RN), a Massachusetts-based public benefit corporation focused on cannabis research and technology. C3RN is collaborating with leading academic institutions, data scientists, the cannabis industry, and healthcare providers to conduct rigorous cannabis research studies and to implement evidence-based findings into practice.AmeriCann, through its Preferred Partner BASK, Inc. (\"BASK\"), will design and conduct research studies with C3RN and its academic and healthcare partners to better understand the therapeutic benefits of cannabis and improve product offerings including AmeriCann's Solanna line of products.\"We are excited to announce a formal partnership with AmeriCann to conduct research and programs to improve the quality of life for medical cannabis patients. AmeriCann's commitment to exploring innovative research approaches using digital health tools and advanced data analytics is a model for other cannabis businesses to follow,\" stated, Dr. Marion McNabb, CEO of C3RN. She went on to say, \"We hope other industry partners will also embrace incorporating the latest technologies, best practices, standards, and collaborative research approaches to continue to explore the benefits of medical and adult use cannabis.\" AmeriCann is developing the Massachusetts Medical Cannabis Center (MMCC), a state-of-the-art cannabis cultivation and processing development in the midst of the rapidly growing Massachusetts medical cannabis market. The MMCC project is approved for 1 million square feet, which will be developed in phases and is expected to be one of the most technologically advanced cultivation facilities in the nation.C3RN was formed in January 2017 to establish a Virtual Cannabis Center of Excellence (CoE). The virtual CoE is a global collaborative network of academics, cannabis industry, healthcare providers, and consumers/patients to advance cannabis science, research, and best practices. The overal...